Mesothelioma pathogenesis, facts and expectations

被引:4
作者
Jaurand, MC [1 ]
机构
[1] Fac Med, INSERM, E 0337, F-94010 Creteil, France
来源
PATHOLOGIE BIOLOGIE | 2005年 / 53卷 / 01期
关键词
asbestos; mesothelioma; NF2; SV40; tumour supressor genes;
D O I
10.1016/j.patbio.2003.10.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
It is the merit of Dr J.C. Wagner and his co-workers to have triggered the research on mesothelioma, going back to 1960 when the.), published data demonstrating a relationship between mesothelioma occurrence and exposure to asbestos fibres in the Cape Province. in South Africa. From that time, epidemiological and toxicological investigations were performed in order to better define the occupational and environmental background of this pathology, to identify the fibre parameters accounting for the toxic effects, and to understand their mechanisms of action. Improvements in our knowledge in these areas benefited to health issues, by preventing risks associated with exposure to mineral fibres and by recognising the disease. Due to the actual progresses in the fields of biology and biotechnologies. the research on mesothetioma presently focuses on study of the mechanisms of mesothelial cell transformation. and on development of strategies to kill tumour cells. While mesothelioma benefited to fibre toxicology and allowed to improve the management health related issue, it would be a just return if the present advances in different scientific areas will permit a rapid eradication of the disease. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:41 / 44
页数:4
相关论文
共 34 条
[21]   MESOTHELIOMAS IN RATS FOLLOWING INOCULATION WITH ACID-LEACHED CHRYSOTILE ASBESTOS AND OTHER MINERAL FIBERS [J].
MONCHAUX, G ;
BIGNON, J ;
JAURAND, MC ;
LAFUMA, J ;
SEBASTIEN, P ;
MASSE, R ;
HIRSCH, A ;
GONI, J .
CARCINOGENESIS, 1981, 2 (03) :229-236
[22]  
Murthy SS, 1999, J CELL PHYSIOL, V180, P150, DOI 10.1002/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO
[23]  
2-H
[24]  
Mutsaers SE, 2000, J PATHOL, V190, P86
[25]   Absence of SV40 large T-antigen expression in human mesothelioma cell lines [J].
Pilatte, Y ;
Vivo, C ;
Renier, A ;
Kheuang, L ;
Greffard, A ;
Jaurand, MC .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000, 23 (06) :788-793
[26]   Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases [J].
Shukla, A ;
Gulumian, M ;
Hei, TK ;
Kamp, D ;
Rahman, Q ;
Mossman, BT .
FREE RADICAL BIOLOGY AND MEDICINE, 2003, 34 (09) :1117-1129
[27]   Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: Results of a phase I clinical trial in malignant mesothelioma [J].
Sterman, DH ;
Treat, J ;
Litzky, LA ;
Amin, KM ;
Coonrod, L ;
Molnar-Kimber, K ;
Recio, A ;
Knox, L ;
Wilson, JM ;
Albelda, SM ;
Kaiser, LR .
HUMAN GENE THERAPY, 1998, 9 (07) :1083-1092
[28]   MESOTHELIOMA IN RATS FOLLOWING INTRAPLEURAL INJECTION OF CHRYSOTILE AND PHOSPHORYLATED CHRYSOTILE (CHRYSOPHOSPHATE) [J].
VANDERMEEREN, A ;
FLEURY, J ;
NEBUT, M ;
MONCHAUX, G ;
JANSON, X ;
JAURAND, MC .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (06) :937-942
[29]   Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+/- mice [J].
Vaslet, CA ;
Messier, NJ ;
Kane, AB .
TOXICOLOGICAL SCIENCES, 2002, 68 (02) :331-338
[30]  
VERSNEL MA, 1994, LUNG BIOL HEALTH DIS, V78, P169